Interaction between polymorphisms of the Human Leukocyte Antigen and HPV-16 Variants on the risk of invasive cervical cancer

BMC Cancer

Volumn 8, Issue , 2008, Pages

  de Araujo Souza, Patricia S ^a,b,f   Maciag, Paulo C ^a,b,g   Ribeiro, Karina B ^c   Petzl Erler, Maria Luiza ^d   Franco, Eduardo L ^e   Villa, Luisa L ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^e MCGILL UNIVERSITY   (Canada)

^f INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^g ADVAXIS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; HLA ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; THYMINE; HLA ANTIGEN CLASS 2;

AFRICA; ARTICLE; ASIAN AMERICAN; CANCER INVASION; CANCER RISK; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; VIRUS STRAIN; CASE CONTROL STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; REGRESSION ANALYSIS; RISK; UTERINE CERVIX TUMOR;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMAN PAPILLOMAVIRUS 16; HUMANS; LINKAGE DISEQUILIBRIUM; NEOPLASM INVASIVENESS; ODDS RATIO; POLYMORPHISM, GENETIC; REGRESSION ANALYSIS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 52749088075     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-246     Document Type: Article

References (53)

1. Ferlay J Bray F Pisani P Parkin DM GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5. version 2.0 IARC Press, Lyon 2004. http://www-dep.iarc.fr/
2. Schlecht NF Kulaga S Robitaille J Ferreira S Santos M Miyamura RA Duarte-Franco E Rohan TE Ferenczy A Villa LL Franco EL Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia JAMA 2001, 286:3106-14. 10.1001/jama.286.24.3106 11754676
3. Trottier H Franco EL The epidemiology of genital human papillomavirus infection Vaccine 2006, 24(Suppl 1):S1-15. 16406226
4. Walboomers JM Jacobs MV Manos MM Bosch FX Kummer JA Shah KV Snijders PJ Peto J Meijer CJ Muñoz N Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 1999, 189:12-9. 10.1002/ (SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F 10451482
5. Ho L Chan SY Burk RD Das BC Fujinaga K Icenogle JP Kahn T Kiviat N Lancaster W Mavromara-Nazos P Labropoulou V Mitrani-Rosenbaum S Norrild B Pillai Mr Stoerker J Syrjaenen K Tay SK Villa LL Wheeler CM Williamson AL Bernard HU The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations J Virol 1993, 67:6413-23. 238076 8411343
6. Villa LL Sichero L Rahal P Caballero O Ferenczy A Rohan T Franco EL Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia J Gen Virol 2000, 81(Pt 12):2959-68. 11086127
7. Berumen J Ordoñez RM Lazcano E Salmeron J Galvan SC Estrada RA Yunes E Garcia-Carranca A Gonzalez-Lira G Madrigal-de la Campa A Asian-American variants of human papillomavirus 16 and risk for cervical cancer: A case-control study J Natl Cancer Inst 2001, 93:1325-30. 10.1093/jnci/93.17.1325 11535707
8. Stoppler MC Ching K Stoppler H Clancy K Schlegel R Icenogle J Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation J Virol 1996, 70:6987-93. 190749 8794343
9. Chakrabarti O Veeraraghavalu K Tergaonkar V Liu Y Androphy EJ Stanley MA Krishna S Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras J Virol 2004, 78:5934-45. 415794 15140991 10.1128/JVI.78.11.5934-5945.2004
10. Asadurian Y Kurilin H Lichtig H Jackman A Gonen P Tommasino M Zehbe I Sherman L Activities of human papillomavirus 16 E6 natural variants in human keratinocytes J Med Virol 2007, 79:1751-60. 10.1002/jmv.20978 17854024
11. Lichtig H Algrisi M Botzer LE Abadi T Verbitzky Y Jackman A Tommasino M Zehbe I Sherman L HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6 Virology 2006, 350:216-27. 10.1016/j.virol.2006.01.038 16519914
12. Londesborough P Ho L Terry G Cuzick J Wheeler C Singer A Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities Int J Cancer 1996, 69:364-8. 10.1002/ (SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3 8900368
13. Zehbe I Wilander E Delius H Tommasino M Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype Cancer Res 1998, 58:829-33. 9485042
14. Stanley M Immune responses to human papillomavirus Vaccine 2006, 24:S16-22. 10.1016/j.vaccine.2005.09.002 16219398
15. Wank R Thomssen C High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3 Nature 1991, 352:723-5. 10.1038/352723a0 1876187
16. David AL Taylor GM Gokhale D Aplin JD Seif MW Tindall VR HLA-DQB1*03 and cervical intraepithelial neoplasia type III Lancet 1992, 340:52. 10.1016/0140-6736(92)92464-Q 1351625
17. Apple RJ Becker TM Wheeler CM Erlich HA Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma J Natl Cancer Inst 1995, 87:427-36. 10.1093/ jnci/87.6.427 7861462
18. de Araujo Souza PS Villa LL Genetic susceptibility to infection with human papillomavirus and development of cervical cancer in women in Brazil Mutat Res 2003, 544:375-83. 10.1016/j.mrrev.2003.06.013 14644340
19. Maciag PC Schlecht NF Souza PS Franco EL Villa LL Petzl-Erler ML Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women Cancer Epidemiol Biomarkers Prev 2000, 9(11):1183-1191. 11097225
20. Cuzick J Terry G Ho L Monaghan J Lopes A Clarkson P Duncan I Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women Br J Cancer 2000, 82:1348-52. 10.1054/ bjoc.1999.1103 10755413
21. Odunsi K Terry G Ho L Bell J Cuzick J Ganesan TS Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles Int J Cancer 1996, 67:595-602. 10.1002/(SICI)1097-0215(19960904)67:5<595::AID-IJC1>3.0.CO;2-P 8782644
22. Sanjeevi CB Hjelmström P Hallmans G Wiklund F Lenner P Angström T Dillner J Lernmark A Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women Int J Cancer 1996, 68:409-14. 10.1002/ (SICI)1097-0215(19961115)68:4<409::AID-IJC1>3.0.CO;2-4 8945607
23. Apple RJ Erlich HA Klitz W Manos MM Becker TM Wheeler CM HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity Nat Genet 1994, 6:157-62. 10.1038/ng0294-157 8162070
24. Hildesheim A Schiffman M Scott DR Marti D Kissner T Sherman ME Glass AG Manos MM Lorincz AT Kurman RJ Buckland J Rush BB Carrington M Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case-control study conducted in the United States Cancer Epidemiol Biomarkers Prev 1998, 7:1035-41. 9829713
25. Matsumoto K Yasugi T Nakagawa S Okubo M Hirata R Maeda H Yoshikawa H Taketani Y Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer Int J Cancer 2003, 106:919-22. 10.1002/ijc.11332 12918070
26. Zehbe I Tachezy R Mytilineos J Voglino G Mikyskova I Delius H Marongiu A Gissmann L Wilander E Tommasino M Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes Int J Cancer 2001, 94:711-6. 10.1002/ijc.1520 11745467
27. Bontkes HJ van Duin M de Gruijl TD Duggan-Keen MF Walboomers JM Stukart MJ Verheijen RH Helmerhorst TJ Meijer CJ Scheper RJ Stevens FR Dyer PA Sinnott P Stern PL HPV 16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV 16 E6 sequence variants Int J Cancer 1998, 78:166-71. 10.1002/ (SICI)1097-0215(19981005)78:2<166::AID-IJC8>3.0.CO;2-X 9754647
28. Beskow AH Engelmark MT Magnusson JJ Gyllensten UB Interaction of host and viral risk factors for development of cervical carcinoma in situ Int J Cancer 2005, 117:690-2. 10.1002/ijc.21212 15929080
29. Franco EL Villa LL Ruiz A Costa MC Transmission of cervical human papillomavirus infection by sexual activity: Differences between low and high oncogenic types J Infect Dis 1995, 172:756-63. 7658069
30. Ting Y Manos M Detection and typing of genital human papillomaviruses PCR protocols. A guide to methods and applications Academic Press, Inc Innis MA, Gelfand DH, Sninsky JJ, White TJ 1990:356-59.
31. Bauer HM Ting Y Greer CE Chambers JC Tashiro CJ Chimera J Reingold A Manos MM Genital human papillomavirus infection in female university students as determined by a PCR-based method JAMA 1991, 265:472-477. 10.1001/jama.265.4.472 1845912
32. Hildesheim A Gravitt P Schiffman MH Kurman RJ Barnes W Jones S Tchabo JG Brinton LA Copeland C Epp J Manos MM Determinants of genital human papillomavirus infection in low-income women in Washington, D.C Sex Transm Dis 1993, 20:279-85. 8235926
33. Wheeler CM Yamada T Hildesheim A Jenison SA Human papillomavirus type 16 sequence variants: Identification by E6 and L1 lineage-specific hybridization J Clin Microbiol 1997, 35:11-9. 229505 8968874
34. Yamada T Wheeler CM Halpern AL Stewart AC Hildesheim A Jenison SA Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments J Virol 1995, 69:7743-53. 189716 7494284
35. Yamada T Manos MM Peto J Greer CE Munoz N Bosch FX Wheeler CM Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective J Virol 1997, 71:2463-72. 191357 9032384
36. Fernandez-Viña MA Bignon JD Primers and oligonucleotide probes (SSOP) used for DNA typing of HLA class II alleles Genetic Diversity of HLA Functional and Medical Implications, Paris: EDK Charron D 1997, I:596-632.
37. Zehbe I Voglino G Delius H Wilander E Tommasino M Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms Lancet 1998, 352:1441-2. 10.1016/S0140-6736(05)61263-9 9807995
38. Hildesheim A Wang SS Host and viral genetics and risk of cervical cancer: A review Virus Res 2002, 89:229-40. 10.1016/ S0168-1702(02)00191-0 12445662
39. Kammer C Warthorst U Torrez-Martinez N Wheeler CM Pfister H Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity J Gen Virol 2000, 81:1975-81. 10900036
40. Sichero L Franco EL Villa LL Different P105 promoter activities among natural variants of human papillomavirus type 18 J Infect Dis 2005, 191:739-42. 10.1086/427825 15688288
41. Apple RJ Becker TM Wheeler CM Erlich HA Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma J Natl Cancer Inst 1995, 87(6):427-36. 10.1093/jnci/87.6.427 7861462
42. Krul EJ Schipper RF Schreuder GM Fleuren GJ Kenter GG Melief CJ HLA and susceptibility to cervical neoplasia Hum Immunol 1999, 60:337-42. 10.1016/S0198-8859(98)00127-X 10363725
43. Beskow AH Josefsson AM Gyllensten UB HLA class II alleles associated with infection by HPV16 in cervical cancer in situ Int J Cancer 2001, 93:817-22. 10.1002/ijc.1412 11519043
44. Wang SS Wheeler CM Hildesheim A Schiffman M Herrero R Bratti MC Sherman ME Alfaro M Hutchinson ML Morales J Lorincz A Burk RD Carrington M Erlich HA Apple RJ Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: Results from a population-based study in Costa Rica J Infect Dis 2001, 184:1310-4. 10.1086/324209 11679920
45. Sastre-Garau X Loste MN Vincent-Salomon A Favre M Mouret E de la Rochefordiere A Durand JC Tartour E Lepage V Charron D Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix Int J Cancer 1996, 69:159-64. 10.1002/ (SICI)1097-0215(19960621)69:3<159::AID-IJC1>3.0.CO;2-Z 8682580
46. Terry G Ho L Cuzick J Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type Int J Cancer 1997, 73:651-5. 10.1002/ (SICI)1097-0215(19971127)73:5<651::AID-IJC7>3.0.CO;2-W 9398041
47. Kwok WW Domeier ML Raymond FC Byers P Nepom GT Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase J Immunol 1996, 156:2171-7. 8690906
48. Hu J Cladel NM Pickel MD Christensen ND Amino acid residues in the carboxy-terminal region of cottontail rabbit papillomavirus E6 influence spontaneous regression of cutaneous papillomas J Virol 2002, 76:11801-8. 136889 12414922 10.1128/JVI.76.23.11801-11808.2002
49. Kadish AS Ho GY Burk RD Wang Y Romney SL Ledwidge R Angeletti RH Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: Outcome of HPV infection and associated neoplasia J Natl Cancer Inst 1997, 89:1285-93. 10.1093/jnci/89.17.1285 9293919
50. Welters MJ de Jong A Eeden van den SJ Hulst van der JM Kwappenberg KM Hassane S Franken KL Drijfhout JW Fleuren GJ Kenter G Melief CJ Offringa R Burg Van der SH Frequent display of human papillomavirus type 16 E6-specific memory T-helper cells in the healthy population as witness of previous viral encounter Cancer Res 2003, 63:636-41. 12566307
51. Maciag PC Schlecht NF Souza PS Rohan TE Franco EL Villa LL Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection J Infect Dis 2002, 186:164-72. 10.1086/341080 12134251
52. Beskow AH Gyllensten UB Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri Int J Cancer 2002, 101:526-31. 10.1002/ijc.90010 12237892
53. Beskow AH Moberg M Gyllensten UB HLA class II allele control of HPV load in carcinoma in situ of the cervix uteri Int J Cancer 2005, 117:510-4. 10.1002/ijc.21204 15906352